FDA MedWatch News Feed

Welcome to Origin Bioanalytical Laboratory, Inc.

Advance Your Drug Development Programs with Our Specialty Bioanalytical Testing

At Origin Bioanalytical Laboratory, we are dedicated to supporting your drug development programs with our bioanalytical testing services. Our contract research organization (CRO) collaborates with clients worldwide to deliver exceptional and reliable results.

LC-MS/MS Bioanalytical CRO Supporting Drug Development Programs.

LC-MS/MS Analysis

Our Services

Explore our comprehensive range of services designed to meet your needs and provide unparalleled value. We have the expertise to advance your projects with our specialized bioanalytical testing using LC-MS/MS analysis.

About Us

Discover the story behind Origin Bioanalytical Laboratory and meet our passionate team committed to excellence. Learn more about our mission, values, and the people who drive our success.

Our Facility

Our laboratory is equipped with the technology and resources to ensure the highest quality of service. Dive deeper into our facility and see how we support your bioanalytical needs.

Comprehensive

Analytical Solutions

Biological Matrices Testing located in Northern California

Our contract research organization (CRO) provides specialty bioanalytical testing to the biotechnology and pharmaceutical industry for small molecule LC-MS/MS analysis (active drug, metabolites, and co-administrative drugs) in tissues and biological fluids. The bioanalytical services we offer support drug development programs from preclinical to late-stage clinical trials. As bioanalytical experts, we understand the balance between quality scientific data, rapid turnaround times, and cost-effectiveness.

Origin strives to deliver accurate and reliable data within client timelines in a cost-effective manner. By forming strong collaborations with our Sponsors to ensure excellent customer service, Sponsors are able to advance their drug development programs and ultimately contribute to the health and safety of patients around the globe.